YEAR ENDED 31 DECEMBER 2024 | Print & | |||
As | print - | Commercial | ||
Revenue | reported | related | healthcare | Restated |
GBPm | GBPm | GBPm | GBPm | |
Risk | 3,245 | (7) | 98 | 3,336 |
Scientific, Technical & Medical | 3,051 | (329) | (98) | 2,624 |
Legal | 1,899 | (181) | - | 1,718 |
Exhibitions | 1,239 | - | - | 1,239 |
Print & print-related activities | - | 517 | - | 517 |
Total revenue | 9,434 | - | - | 9,434 |
Adjusted operating profit | ||||
Risk | 1,228 | (4) | 9 | 1,233 |
Scientific, Technical & Medical | 1,172 | (182) | (9) | 981 |
Legal | 412 | (31) | - | 381 |
Exhibitions | 398 | - | - | 398 |
Print & print-related activities | - | 217 | - | 217 |
Unallocated central costs | (11) | - | - | (11) |
Total adjusted operating profit | 3,199 | - | - | 3,199 |
YEAR ENDED 31 DECEMBER 2023 | Print & | |||
As | print - | Commercial | ||
Revenue | reported | related | healthcare | Restated |
GBPm | GBPm | GBPm | GBPm | |
Risk | 3,133 | (9) | 100 | 3,224 |
Scientific, Technical & Medical | 3,062 | (381) | (100) | 2,581 |
Legal | 1,851 | (196) | - | 1,655 |
Exhibitions | 1,115 | - | - | 1,115 |
Print & print-related activities | - | 586 | - | 586 |
Total revenue | 9,161 | - | - | 9,161 |
Adjusted operating profit | ||||
Risk | 1,165 | (5) | 10 | 1,170 |
Scientific, Technical & Medical | 1,165 | (215) | (10) | 940 |
Legal | 393 | (33) | - | 360 |
Exhibitions | 319 | - | - | 319 |
Print & print-related activities | - | 253 | - | 253 |
Unallocated central costs | (12) | - | - | (12) |
Total adjusted operating profit | 3,030 | - | - | 3,030 |
ANALYSIS BY REPORTED SEGMENT | Revenue | Adjusted operating profit | ||||
Restated | Restated | Restated | Restated | |||
2023 | 2024 | 2025 | 2023 | 2024 | 2025 | |
GBPm | GBPm | GBPm | GBPm | GBPm | GBPm | |
Risk | 3,224 | 3,336 | 3,485 | 1,170 | 1,233 | 1,305 |
Scientific, Technical & Medical | 2,581 | 2,624 | 2,714 | 940 | 981 | 1,035 |
Legal | 1,655 | 1,718 | 1,806 | 360 | 381 | 415 |
Exhibitions | 1,115 | 1,239 | 1,186 | 319 | 398 | 410 |
Print & print-related activities | 586 | 517 | 399 | 253 | 217 | 185 |
Sub-total | 9,161 | 9,434 | 9,590 | 3,042 | 3,210 | 3,350 |
Unallocated central costs | - | - | - | (12) | (11) | (8) |
Total | 9,161 | 9,434 | 9,590 | 3,030 | 3,199 | 3,342 |
2023 | Print & print- | |||||
Scientific, Technical | related | |||||
Risk | & Medical | Legal | activities | Total | ||
Restated | Restated | Restated | Exhibitions | Restated | Restated | |
GBPm | GBPm | GBPm | GBPm | GBPm | GBPm | |
Revenue by geographical market | ||||||
North America | 2,573 | 1,108 | 1,146 | 217 | 342 | 5,386 |
Europe* | 423 | 593 | 334 | 427 | 131 | 1,908 |
Rest of world | 228 | 880 | 175 | 471 | 113 | 1,867 |
Total revenue | 3,224 | 2,581 | 1,655 | 1,115 | 586 | 9,161 |
Revenue by format | ||||||
Electronic | 3,210 | 2,574 | 1,646 | 85 | - | 7,515 |
Face-to-face | 14 | 7 | 9 | 1,030 | - | 1,060 |
Print | - | - | - | - | 586 | 586 |
Total revenue | 3,224 | 2,581 | 1,655 | 1,115 | 586 | 9,161 |
Revenue by type | ||||||
Subscriptions | 1,330 | 2,107 | 1,363 | - | 176 | 4,976 |
Transactional | 1,894 | 474 | 292 | 1,115 | 410 | 4,185 |
Total revenue | 3,224 | 2,581 | 1,655 | 1,115 | 586 | 9,161 |
2024 | Print & print- | |||||
Scientific, Technical | related | |||||
Risk | & Medical | Legal | activities | Total | ||
Restated | Restated | Restated | Exhibitions | Restated | Restated | |
GBPm | GBPm | GBPm | GBPm | GBPm | GBPm | |
Revenue by geographical market | ||||||
North America | 2,658 | 1,126 | 1,188 | 231 | 292 | 5,495 |
Europe* | 439 | 603 | 351 | 527 | 105 | 2,025 |
Rest of world | 239 | 895 | 179 | 481 | 120 | 1,914 |
Total revenue | 3,336 | 2,624 | 1,718 | 1,239 | 517 | 9,434 |
Revenue by format | ||||||
Electronic | 3,320 | 2,618 | 1,707 | 83 | - | 7,728 |
Face-to-face | 16 | 6 | 11 | 1,156 | - | 1,189 |
Print | - | - | - | - | 517 | 517 |
Total revenue | 3,336 | 2,624 | 1,718 | 1,239 | 517 | 9,434 |
Revenue by type | ||||||
Subscriptions | 1,329 | 2,110 | 1,432 | - | 154 | 5,025 |
Transactional | 2,007 | 514 | 286 | 1,239 | 363 | 4,409 |
Total revenue | 3,336 | 2,624 | 1,718 | 1,239 | 517 | 9,434 |
2025 | Print & print- | |||||
Scientific, Technical | related | |||||
Risk | & Medical | Legal | Exhibitions | activities | Total | |
GBPm | GBPm | GBPm | GBPm | GBPm | GBPm | |
Revenue by geographical market | ||||||
North America | 2,749 | 1,161 | 1,229 | 237 | 219 | 5,595 |
Europe* | 469 | 619 | 391 | 424 | 97 | 2,000 |
Rest of world | 267 | 934 | 186 | 525 | 83 | 1,995 |
Total revenue | 3,485 | 2,714 | 1,806 | 1,186 | 399 | 9,590 |
Revenue by format | ||||||
Electronic | 3,475 | 2,707 | 1,794 | 94 | - | 8,070 |
Face-to-face | 10 | 7 | 12 | 1,092 | - | 1,121 |
Print | - | - | - | - | 399 | 399 |
Total revenue | 3,485 | 2,714 | 1,806 | 1,186 | 399 | 9,590 |
Revenue by type | ||||||
Subscriptions | 1,363 | 2,168 | 1,527 | - | 132 | 5,190 |
Transactional | 2,122 | 546 | 279 | 1,186 | 267 | 4,400 |
Total revenue | 3,485 | 2,714 | 1,806 | 1,186 | 399 | 9,590 |
ANALYSIS OF REVENUE BY GEOGRAPHICAL ORIGIN | 2023 | 2024 | 2025 |
GBPm | GBPm | GBPm | |
North America | 5,325 | 5,461 | 5,551 |
Europe | 3,117 | 3,270 | 3,305 |
Rest of world | 719 | 703 | 734 |
Total | 9,161 | 9,434 | 9,590 |
ANALYSIS BY REPORTED | Expenditure on | |||||||||||
SEGMENT | acquired goodwill and | Capital expenditure | Amortisation of acquired | Total depreciation and | ||||||||
| intangible assets | additions | intangible assets | other amortisation | |||||||||
Restated | Restated | Restated | Restated | Restated | Restated | Restated | Restated | |||||
2023 | 2024 | 2025 | 2023 | 2024 | 2025 | 2023 | 2024 | 2025 | 2023 | 2024 | 2025 | |
GBPm | GBPm | GBPm | GBPm | GBPm | GBPm | GBPm | GBPm | GBPm | GBPm | GBPm | GBPm | |
Risk | 79 | - | 249 | 139 | 148 | 156 | 194 | 184 | 175 | 92 | 99 | 102 |
Scientific, Technical & | ||||||||||||
Medical | 3 | 8 | 5 | 107 | 103 | 116 | 59 | 44 | 39 | 133 | 123 | 124 |
Legal | 42 | 145 | - | 193 | 203 | 225 | 11 | 15 | 20 | 242 | 252 | 239 |
Exhibitions | 8 | 65 | 20 | 37 | 29 | 27 | 16 | 15 | 14 | 39 | 45 | 34 |
Print & print-related | ||||||||||||
activities | - | - | - | 1 | 1 | 1 | - | - | - | 8 | 6 | 5 |
Total | 132 | 218 | 274 | 477 | 484 | 525 | 280 | 258 | 248 | 514 | 525 | 504 |
ANALYSIS OF NON-CURRENT ASSETS BY GEOGRAPHICAL LOCATION | 2024 | 2025 |
GBPm | GBPm | |
North America | 9,131 | 8,545 |
Europe | 2,259 | 2,459 |
Rest of world | 438 | 459 |
Total | 11,828 | 11,463 |
RECONCILIATION OF OPERATING PROFIT TO ADJUSTED OPERATING PROFIT | 2023 | 2024 | 2025 |
GBPm | GBPm | GBPm | |
Operating profit | 2,682 | 2,861 | 3,027 |
Adjustments: | |||
Amortisation of acquired intangible assets | 280 | 258 | 248 |
Acquisition and disposal related items | 56 | 69 | 54 |
Reclassification of tax in joint ventures and associates | 12 | 12 | 14 |
Reclassification of finance income in joint ventures and associates | - | (1) | (1) |
Adjusted operating profit | 3,030 | 3,199 | 3,342 |
2023 | 2024 | 2025 | ||
Note | GBPm | GBPm | GBPm | |
Total staff costs | 5 | 3,108 | 3,120 | 3,175 |
Depreciation and amortisation | ||||
Amortisation of acquired intangible assets | 14 | 279 | 258 | 248 |
Share of joint ventures and associates' amortisation of acquired | ||||
intangible assets | 1 | - | - | |
Amortisation of acquired intangible assets including joint ventures and | ||||
associates' share | 280 | 258 | 248 | |
Amortisation of internally developed intangible assets | 14 | 330 | 364 | 352 |
Depreciation of property, plant and equipment | 16 | 43 | 34 | 26 |
Depreciation of right-of-use assets | 65 | 50 | 37 | |
Amortisation of pre-publication costs | 76 | 77 | 89 | |
Total depreciation and other amortisation | 2 | 514 | 525 | 504 |
Total depreciation and amortisation (including amortisation of acquired | ||||
intangibles) | 794 | 783 | 752 | |
Other expenses | ||||
Cost of sales including pre-publication costs and inventory expenses | 3,216 | 3,300 | 3,233 | |
Short-term and low value lease expenses | 18 | 16 | 15 |
2023 | 2024 | 2025 | |
GBPm | GBPm | GBPm | |
Auditor’s remuneration | |||
Payable to the auditors of RELX PLC | 0.9 | 0.9 | 0.9 |
Payable to the auditors of the Group’s subsidiaries | 8.0 | 7.5 | 7.8 |
Audit services | 8.9 | 8.4 | 8.7 |
Audit-related assurance services | 0.5 | 0.4 | 0.3 |
Other assurance services | 0.2 | 0.5 | 0.7 |
Total auditor’s remuneration | 9.6 | 9.3 | 9.7 |
2023 | 2024 | 2025 | |
GBPm | GBPm | GBPm | |
Staff costs | |||
Wages and salaries | 2,636 | 2,630 | 2,679 |
Social security costs | 274 | 280 | 288 |
Pensions | 142 | 144 | 145 |
Share based remuneration | 56 | 66 | 63 |
Total staff costs | 3,108 | 3,120 | 3,175 |
| At 31 December | Average during the year | |||||
Restated | Restated | Restated | Restated | |||
2023 | 2024 | 2025 | 2023 | 2024 | 2025 | |
Reported segment | ||||||
Risk | 11,100 | 11,000 | 11,800 | 10,900 | 11,000 | 11,400 |
Scientific, Technical & Medical | 9,400 | 9,600 | 9,700 | 9,500 | 9,500 | 9,700 |
Legal | 11,500 | 11,600 | 11,900 | 11,600 | 11,600 | 11,800 |
Exhibitions | 3,500 | 3,300 | 3,400 | 3,500 | 3,500 | 3,300 |
Print & print-related activities | 400 | 300 | 200 | 400 | 300 | 200 |
Sub-total | 35,900 | 35,800 | 37,000 | 35,900 | 35,900 | 36,400 |
Corporate/shared functions | 600 | 600 | 600 | 600 | 600 | 600 |
Total | 36,500 | 36,400 | 37,600 | 36,500 | 36,500 | 37,000 |
Geographical location | ||||||
North America | 14,600 | 14,200 | 14,200 | 14,700 | 14,500 | 14,300 |
Europe | 10,000 | 9,300 | 9,200 | 9,900 | 9,600 | 9,200 |
Rest of world | 11,900 | 12,900 | 14,200 | 11,900 | 12,400 | 13,500 |
Total | 36,500 | 36,400 | 37,600 | 36,500 | 36,500 | 37,000 |
2023 | 2024 | 2025 | |
GBPm | GBPm | GBPm | |
Defined benefit pension expense | 5 | 4 | 3 |
Defined contribution pension expense | 137 | 140 | 142 |
Total | 142 | 144 | 145 |
2023 | 2024 | 2025 | |||||||
UK | US | Total | UK | US | Total | UK | US | Total | |
GBPm | GBPm | GBPm | GBPm | GBPm | GBPm | GBPm | GBPm | GBPm | |
Service cost | 2 | 3 | 5 | 1 | 3 | 4 | - | 2 | 2 |
Past service cost/(settlement credit) | - | - | - | - | - | - | 5 | (4) | 1 |
Defined benefit pension expense | 2 | 3 | 5 | 1 | 3 | 4 | 5 | (2) | 3 |
Net interest on net defined benefit pension | |||||||||
balance | 1 | - | 1 | - | 1 | 1 | (3) | - | (3) |
Net defined benefit pension expense/(credit) | 3 | 3 | 6 | 1 | 4 | 5 | 2 | (2) | - |
AS AT 31 DECEMBER | 2023 | 2024 | 2025 | |||
UK | US | UK | US | UK | US | |
Discount rate | 4.60 % | 5.05 % | 5.55 % | 5.55 % | 5.60 % | 5.25 % |
Inflation | 3.05 % | 2.50 % | 3.15 % | 2.50 % | 2.90 % | 2.50 % |
AS AT 31 DECEMBER 2023 | Male average life | Female average | ||
expectancy | life expectancy | |||
UK | US | UK | US | |
Member currently aged 60 years | 85 | 86 | 88 | 88 |
Member currently aged 45 years | 86 | 86 | 90 | 89 |
AS AT 31 DECEMBER 2024 | Male average life | Female average | ||
expectancy | life expectancy | |||
UK | US | UK | US | |
Member currently aged 60 years | 85 | 86 | 89 | 88 |
Member currently aged 45 years | 86 | 86 | 90 | 89 |
AS AT 31 DECEMBER 2025 | Male average life | Female average | ||
expectancy | life expectancy | |||
UK | US | UK | US | |
Member currently aged 60 years | 85 | 86 | 89 | 88 |
Member currently aged 45 years | 87 | 87 | 90 | 89 |
| 2024 | 2025 | |||||
UK | US | Total | UK | US | Total | |
GBPm | GBPm | GBPm | GBPm | GBPm | GBPm | |
Defined benefit obligation | ||||||
At start of year | (2,984) | (822) | (3,806) | (2,710) | (803) | (3,513) |
Service cost | (1) | (3) | (4) | - | (2) | (2) |
Past service cost | - | - | - | (5) | - | (5) |
Interest on pension scheme liabilities | (133) | (40) | (173) | (147) | (41) | (188) |
Actuarial gains/(losses) on financial assumptions | 301 | 20 | 321 | 57 | (20) | 37 |
Actuarial (losses)/gains arising from experience | ||||||
assumptions | (20) | (3) | (23) | (16) | (3) | (19) |
Contributions by employees | (7) | - | (7) | (7) | - | (7) |
Liabilities transferred on settlement | - | - | - | - | 140 | 140 |
Benefits paid | 134 | 61 | 195 | 137 | 60 | 197 |
Exchange translation differences | - | (16) | (16) | - | 52 | 52 |
At end of yea r | (2,710) | (803) | (3,513) | (2,691) | (617) | (3,308) |
Fair value of scheme assets | ||||||
At start of yea r | 2,937 | 834 | 3,771 | 2,744 | 800 | 3,544 |
Interest income on plan assets | 133 | 39 | 172 | 150 | 41 | 191 |
Return on assets excluding amounts included in | ||||||
interest income | (240) | (33) | (273) | (29) | 32 | 3 |
Contributions by employer | 41 | 7 | 48 | 13 | 6 | 19 |
Contributions by employees | 7 | - | 7 | 7 | - | 7 |
Assets transferred on settlement | - | - | - | - | (136) | (136) |
Benefits paid | (134) | (61) | (195) | (137) | (60) | (197) |
Exchange translation differences | - | 14 | 14 | - | (53) | (53) |
At end of year | 2,744 | 800 | 3,544 | 2,748 | 630 | 3,378 |
Opening net balance | (47) | 12 | (35) | 34 | (3) | 31 |
Service cost | (1) | (3) | (4) | - | (2) | (2) |
Net interest on net defined benefit balance | - | (1) | (1) | 3 | - | 3 |
(Past service cost)/settlement credit | - | - | - | (5) | 4 | (1) |
Contributions by employer | 41 | 7 | 48 | 13 | 6 | 19 |
Actuarial (losses)/gains | 41 | (16) | 25 | 12 | 9 | 21 |
Exchange translation differences | - | (2) | (2) | - | (1) | (1) |
Net pension balance | 34 | (3) | 31 | 57 | 13 | 70 |
Impact of asset ceiling | (4) | (6) | (10) | (5) | (22) | (27) |
Overall net pension balance | 30 | (9) | 21 | 52 | (9) | 43 |
2024 | 2025 | |
GBPm | GBPm | |
Net pension asset recognised | 186 | 197 |
Net pension obligation | (165) | (154) |
Overall net pension balance | 21 | 43 |
2023 | 2024 | 2025 | |
GBPm | GBPm | GBPm | |
Gains and losses arising during the year: | |||
Experience losses on scheme liabilities | (11) | (23) | (19) |
Experience gains/(losses) on scheme assets | 35 | (273) | 3 |
Actuarial (losses)/gains on the present value of scheme liabilities due to changes in: | |||
– discount rates | (145) | 374 | (5) |
– inflation | 15 | (36) | 43 |
– other actuarial assumptions | 50 | (17) | (1) |
(56) | 25 | 21 |
FAIR VALUE OF SCHEME ASSETS | 2024 | 2025 | ||||
UK | US | Total | UK | US | Total | |
GBPm | GBPm | GBPm | GBPm | GBPm | GBPm | |
Equities ¹ | 419 | 2 | 421 | 311 | 1 | 312 |
Liability matching assets ² | 1,716 | 784 | 2,500 | 1,929 | 620 | 2,549 |
Property funds and ground leases ³ | 172 | - | 172 | 100 | - | 100 |
Direct lending and multi-asset credit funds | 333 | - | 333 | 300 | - | 300 |
Cash and cash equivalents ⁴ | 96 | 14 | 110 | 101 | 9 | 110 |
Othe r | 8 | - | 8 | 7 | - | 7 |
Total | 2,744 | 800 | 3,544 | 2,748 | 630 | 3,378 |
GBPm | |
Increase/decrease of 0.5% in discount rate | 174 |
Increase/decrease of 0.25% in the expected inflation rate | 55 |
Increase/decrease of one year in assumed life expectancy | 77 |
2023 | 2024 | 2025 | |
GBPm | GBPm | GBPm | |
Interest on short-term bank loans, overdrafts and commercial paper | (31) | (48) | (47) |
Interest on term debt | (263) | (228) | (222) |
Interest on lease liabilities | (6) | (5) | (4) |
Total borrowing costs | (300) | (281) | (273) |
Losses on loans and derivatives not designated as hedges | (20) | (20) | (30) |
Fair value (losses)/gains on designated fair value hedge relationships | (2) | (2) | 2 |
Net interest on defined benefit pension schemes | (1) | (1) | 3 |
Finance costs | (323) | (304) | (298) |
Interest on bank deposits | 8 | 6 | 12 |
Finance income | 8 | 6 | 12 |
Net finance costs | (315) | (298) | (286) |
2023 | 2024 | 2025 | |
GBPm | GBPm | GBPm | |
Revaluation of investments | (11) | (2) | 12 |
Loss on disposal of businesses | (61) | (4) | (3) |
Net loss on disposals and othe r non-operating items | (72) | (6) | 9 |
2023 |
2024 |
2025 |
|
GBPm |
GBPm |
GBPm |
|
Current tax |
|||
Current yea r |
(652) |
(661) |
(750) |
Prior years |
77 |
54 |
24 |
Total current tax charge |
(575) |
(607) |
(726) |
Deferred tax |
68 |
(6) |
54 |
Tax charge |
(507) |
(613) |
(672) |
2023 |
2024 |
2025 |
||||
GBPm |
% |
GBPm |
% |
GBPm |
% |
|
Profit before tax |
2,295 |
2,557 |
2,750 |
|||
Tax at average applicable rates |
(571) |
24.9 % |
(647) |
25.3 % |
(687) |
25.0 % |
Tax effect of share of results of joint ventures |
||||||
and associates |
8 |
(0.3)% |
9 |
(0.4)% |
11 |
(0.4)% |
Income not taxable and expenses not deductible |
20 |
(0.9)% |
16 |
(0.6)% |
8 |
(0.3)% |
Non-deductible costs of share based |
||||||
remuneration |
(1) |
0.0 % |
(2) |
0.1 % |
(1) |
0.0 % |
Non-deductible disposal-related losses |
(22) |
1.0 % |
(7) |
0.3 % |
(24) |
0.9 % |
Deferred tax assets of the period not recognised |
(3) |
0.1 % |
(18) |
0.7 % |
(2) |
0.1 % |
Change in recognition and measurement of |
||||||
deferred tax |
4 |
(0.2)% |
13 |
(0.5)% |
16 |
(0.6)% |
Movements in provisions and prior year items |
58 |
(2.5)% |
23 |
(0.9)% |
7 |
(0.3)% |
Tax charge |
(507) |
22.1 % |
(613) |
24.0 % |
(672) |
24.4 % |
2023 |
2024 |
2025 |
|
GBPm |
GBPm |
GBPm |
|
Tax on items that will not be reclassified to profit or loss |
|||
Tax on actuarial movements on defined benefit pension schemes |
19 |
(11) |
(3) |
Tax on items that may be reclassified to profit or loss |
|||
Tax on fair value movements on cash flow hedges |
(12) |
3 |
(5) |
Net tax (charge)/credit recognised in other comprehensive income |
7 |
(8) |
(8) |
Tax credit on share based remuneration recognised directly in equity |
24 |
20 |
21 |
2024 |
2025 |
|
GBPm |
GBPm |
|
Current tax assets |
42 |
13 |
Current tax liabilities |
(119) |
(153) |
Total |
(77) |
(140) |
2024 |
2025 |
|
GBPm |
GBPm |
|
Deferred tax assets |
84 |
75 |
Deferred tax liabilities |
(473) |
(405) |
Total |
(389) |
(330) |
Deferred tax liabilities |
Deferred tax assets |
||||||
Acquired |
Other |
Acquired |
Losses and |
Other |
|||
intangible |
temporary |
intangible |
other tax |
Pension |
temporary |
||
assets |
differences |
assets |
attributes |
balances |
differences |
Total |
|
GBPm |
GBPm |
GBPm |
GBPm |
GBPm |
GBPm |
GBPm |
|
Deferred tax (liability)/asset |
|||||||
at 1 January 2024 |
(652) |
(182) |
99 |
96 |
47 |
247 |
(345) |
Credit/(charge) to profit |
52 |
14 |
(31) |
(31) |
(10) |
- |
(6) |
(Charge)/credit to equity/other |
|||||||
comprehensive income |
- |
(14) |
- |
- |
6 |
1 |
(7) |
Acquisitions |
(16) |
- |
- |
1 |
- |
- |
(15) |
Disposals and othe r |
- |
- |
- |
- |
- |
(2) |
(2) |
Exchange translation differences |
(10) |
(1) |
(2) |
(2) |
- |
1 |
(14) |
Deferred tax (liability)/asset |
|||||||
at 1 January 2025 |
(626) |
(183) |
66 |
64 |
43 |
247 |
(389) |
Credit/(charge) to profit |
52 |
22 |
(31) |
- |
(3) |
14 |
54 |
(Charge)/credit to equity/other |
|||||||
comprehensive income |
- |
(8) |
- |
- |
1 |
3 |
(4) |
Acquisitions |
(25) |
- |
- |
- |
- |
- |
(25) |
Disposals and othe r |
- |
- |
- |
- |
- |
- |
- |
Exchange translation differences |
36 |
7 |
2 |
- |
(1) |
(10) |
34 |
Deferred tax (liability)/asset at |
|||||||
31 December 2025 |
(563) |
(162) |
37 |
64 |
40 |
254 |
(330) |
2024 |
2025 |
|||
GBPm |
GBPm |
GBPm |
GBPm |
|
Gross amount |
Tax effected |
Gross amount |
Tax effected |
|
Trading losses and temporary differences expiring |
||||
Within 10 years |
55 |
15 |
59 |
13 |
More than 10 years |
13 |
3 |
10 |
2 |
Available indefinitely |
185 |
51 |
100 |
25 |
Total |
253 |
69 |
169 |
40 |
State and local tax losses expiring |
||||
Within 10 years |
18 |
1 |
18 |
1 |
More than 10 years |
57 |
3 |
48 |
3 |
Available indefinitely |
- |
- |
- |
- |
Total |
75 |
4 |
66 |
4 |
Capital losses expiring |
||||
Within 10 years |
- |
- |
- |
- |
More than 10 years |
- |
- |
- |
- |
Available indefinitely |
140 |
31 |
144 |
32 |
Total |
140 |
31 |
144 |
32 |
EARNINGS PER SHARE – FOR THE | |||||||||
YEAR ENDED 31 DECEMBER | 2023 | 2024 | 2025 | ||||||
Weighted | Weighted | Weighted | |||||||
Net profit | average | Net profit | average | Net profit | average | ||||
attributable to | number | attributable to | number | attributable to | number | ||||
shareholders | of shares | EPS | shareholders | of shares | EPS | shareholders | of shares | EPS | |
GBPm | (millions) | (pence) | GBPm | (millions) | (pence) | GBPm | (millions) | (pence) | |
Basic earnings per share | 1,781 | 1,891.8 | 94.1 | 1,934 | 1,865.9 | 103.6p | 2,065 | 1,834.4 | 112.6p |
Diluted earnings per share | 1,781 | 1,902.8 | 93.6 | 1,934 | 1,876.7 | 103.1p | 2,065 | 1,843.5 | 112.0p |
2023 |
2024 |
2025 |
||
RECONCILIATION OF OPERATING PROFIT TO CASH GENERATED FROM OPERATIONS |
Note |
GBPm |
GBPm |
GBPm |
Operating profit |
2,682 |
2,861 |
3,027 |
|
Share of results of joint ventures and associates |
(46) |
(43) |
(44) |
|
Amortisation of acquired intangible assets |
279 |
258 |
248 |
|
Amortisation of internally developed intangible assets |
330 |
364 |
352 |
|
Amortisation of pre-publication costs |
76 |
77 |
89 |
|
Depreciation of property, plant and equipment |
43 |
34 |
26 |
|
Depreciation of right-of-use assets |
65 |
50 |
37 |
|
Share based remuneration |
5 |
56 |
66 |
63 |
Total non-cash items |
849 |
849 |
815 |
|
Increase in inventories and pre-publication costs |
(90) |
(83) |
(101) |
|
(Increase)/decrease in receivables |
(24) |
(173) |
14 |
|
(Decrease)/increase in payables |
(1) |
110 |
24 |
|
Increase in working capital |
(115) |
(146) |
(63) |
|
Cash generated from operations |
3,370 |
3,521 |
3,735 |
CASH FLOW ON ACQUISITIONS |
2023 |
2024 |
2025 |
|
Note |
GBPm |
GBPm |
GBPm |
|
Purchase of businesses |
12 |
(108) |
(165) |
(242) |
Deferred payments relating to prior year acquisitions |
(16) |
(5) |
(18) |
|
Total |
(124) |
(170) |
(260) |
RECONCILIATION OF NET DEBT |
Derivative |
Cross- |
||||
financial |
currency |
|||||
instruments |
interest rate |
|||||
Cash and |
in fair value |
swaps not |
Finance |
|||
cash |
hedging |
designated |
Lease |
|||
equivalents |
Debt |
relationships |
as hedges |
receivable |
Total |
|
GBPm |
GBPm |
GBPm |
GBPm |
GBPm |
GBPm |
|
At 1 January 2024 |
155 |
(6,497) |
(108) |
- |
4 |
(6,446) |
Decrease in cash and cash equivalents |
(32) |
- |
- |
- |
- |
(32) |
Increase in short-term bank loans, overdrafts |
||||||
and commercial paper |
- |
(461) |
- |
- |
- |
(461) |
Issuance of term debt |
- |
(711) |
- |
- |
- |
(711) |
Repayment of term debt |
- |
1,017 |
- |
- |
- |
1,017 |
Repayment of leases |
- |
63 |
- |
- |
(2) |
61 |
Change in net debt resulting from cash flows |
(32) |
(92) |
- |
- |
(2) |
(126) |
Borrowings in disposed businesses |
- |
8 |
- |
- |
- |
8 |
Remeasurement and derecognition of leases |
- |
(4) |
- |
- |
- |
(4) |
Inception of leases |
- |
(32) |
- |
- |
- |
(32) |
Fair value and other adjustments to debt and |
||||||
related derivatives |
- |
19 |
(28) |
- |
- |
(9) |
Exchange translation differences |
(4) |
54 |
(4) |
- |
- |
46 |
At 1 January 2025 |
119 |
(6,544) |
(140) |
- |
2 |
(6,563) |
Increase in cash and cash equivalents |
15 |
- |
- |
- |
- |
15 |
Increase in short-term bank loans, overdrafts |
||||||
and commercial paper |
- |
(232) |
- |
- |
- |
(232) |
Issuance of term debt |
- |
(1,125) |
- |
- |
- |
(1,125) |
Repayment of term debt |
- |
621 |
- |
- |
- |
621 |
Repayment of leases |
- |
40 |
- |
- |
(2) |
38 |
Change in net debt resulting from cash flows |
15 |
(696) |
- |
- |
(2) |
(683) |
Borrowings in acquired businesses |
- |
(2) |
- |
- |
- |
(2) |
Remeasurement and derecognition of leases |
- |
(1) |
- |
- |
- |
(1) |
Inception of leases |
- |
(35) |
- |
- |
- |
(35) |
Fair value and other adjustments to debt and |
||||||
related derivatives |
- |
(77) |
70 |
(5) |
- |
(12) |
Exchange translation differences |
(3) |
88 |
10 |
- |
- |
95 |
At 31 December 2025 |
131 |
(7,267) |
(60) |
(5) |
- |
(7,201) |
Fair value | Fair value | Fair value | |
2023 | 2024 | 2025 | |
GBPm | GBPm | GBPm | |
Goodwill | 68 | 146 | 140 |
Intangible assets | 64 | 72 | 134 |
Property, plant and equipment | 1 | - | - |
Current assets | 3 | 6 | 3 |
Current liabilities | (10) | (14) | (6) |
Borrowings | - | - | (2) |
Deferred tax | (6) | (15) | (25) |
Net assets acquired | 120 | 195 | 244 |
Consideration (after taking account of £1m net cash acquired (2024: £7m; 2023: £4m)) | 120 | 195 | 244 |
Change in consideration deferred to future years and changes in contingent | |||
consideration relating to prior year acquisitions | (12) | (30) | (2) |
Net cash flo w | 108 | 165 | 242 |
ORDINARY DIVIDENDS PAID IN THE YEAR | 2023 | 2024 | 2025 |
GBPm | GBPm | GBPm | |
RELX PLC | 1,059 | 1,121 | 1,181 |
■ |
Market-related assets – 1 to 40 years |
■ |
Customer-related assets – 1 to 20 years |
■ |
Editorial content – 1 to 40 years |
■ |
Software and systems – 1 to 10 years |
■ |
Other – 3 to 20 years |
Total |
|||||||||
Total |
Internally |
intangible |
|||||||
Software |
acquired |
developed |
assets |
||||||
Market |
Customer |
Editorial |
and |
intangible |
intangible |
excluding |
|||
Goodwill |
related |
related |
content |
technology |
Other |
assets |
assets |
goodwill |
|
GBPm |
GBPm |
GBPm |
GBPm |
GBPm |
GBPm |
GBPm |
GBPm |
GBPm |
|
COST |
|||||||||
As at 1 January 2024 |
8,023 |
2,540 |
1,979 |
658 |
835 |
2,426 |
8,438 |
4,343 |
12,781 |
Acquisitions |
146 |
10 |
14 |
10 |
38 |
- |
72 |
- |
72 |
Additions |
- |
- |
- |
- |
- |
- |
- |
464 |
464 |
Disposals and other |
(36) |
(71) |
(8) |
(6) |
(23) |
(110) |
(218) |
(87) |
(305) |
Exchange translation differences |
83 |
36 |
25 |
4 |
5 |
7 |
77 |
2 |
79 |
At 1 January 2025 |
8,216 |
2,515 |
2,010 |
666 |
855 |
2,323 |
8,369 |
4,722 |
13,091 |
Acquisitions |
140 |
20 |
70 |
4 |
34 |
6 |
134 |
- |
134 |
Additions |
- |
- |
- |
- |
- |
- |
- |
504 |
504 |
Disposals and other |
- |
- |
- |
- |
(99) |
(19) |
(118) |
(186) |
(304) |
Exchange translation differences |
(426) |
(158) |
(117) |
(24) |
(34) |
(80) |
(413) |
(160) |
(573) |
At 31 December 2025 |
7,930 |
2,377 |
1,963 |
646 |
756 |
2,230 |
7,972 |
4,880 |
12,852 |
ACCUMULATED AMORTISATION |
|||||||||
As at 1 January 2024 |
- |
1,731 |
1,323 |
607 |
600 |
2,416 |
6,677 |
2,866 |
9,543 |
Charge for the year |
- |
111 |
71 |
13 |
62 |
1 |
258 |
364 |
622 |
Disposals and other |
- |
(69) |
(8) |
(5) |
(23) |
(110) |
(215) |
(71) |
(286) |
Exchange translation differences |
- |
23 |
15 |
3 |
6 |
7 |
54 |
(6) |
48 |
At 1 January 2025 |
- |
1,796 |
1,401 |
618 |
645 |
2,314 |
6,774 |
3,153 |
9,927 |
Charge for the year |
- |
108 |
69 |
12 |
57 |
2 |
248 |
352 |
600 |
Disposals and other |
- |
- |
- |
- |
(99) |
(19) |
(118) |
(204) |
(322) |
Exchange translation differences |
- |
(114) |
(82) |
(22) |
(31) |
(80) |
(329) |
(96) |
(425) |
At 31 December 2025 |
- |
1,790 |
1,388 |
608 |
572 |
2,217 |
6,575 |
3,205 |
9,780 |
NET BOOK AMOUNT |
|||||||||
At 31 December 2024 |
8,216 |
719 |
609 |
48 |
210 |
9 |
1,595 |
1,569 |
3,164 |
At 31 December 2025 |
7,930 |
587 |
575 |
38 |
184 |
13 |
1,397 |
1,675 |
3,072 |
GOODWILL |
2024 |
2025 |
GBPm |
GBPm |
|
Risk |
4,004 |
3,902 |
Scientific, Technical & Medical |
1,948 |
1,814 |
Legal |
1,640 |
1,543 |
Exhibitions |
624 |
631 |
Print & print-related |
- |
40 |
Total |
8,216 |
7,930 |
KEY ASSUMPTIONS |
2024 |
2025 |
||
Nominal |
Nominal |
|||
Pre-tax |
long-term |
Pre-tax |
long-term |
|
discount |
market |
discount |
market |
|
rate |
growth rate |
rate |
growth rate |
|
Risk |
11.3% |
4% |
11.3% |
4% |
Scientific, Technical & Medical |
10.6% |
3% |
10.6% |
3% |
Legal |
10.9% |
4% |
10.9% |
4% |
Exhibitions |
12.3% |
4% |
12.3% |
4% |
Print & print-related |
- |
- |
13.8% |
(9)% |
2024 |
2025 |
|
GBPm |
GBPm |
|
Investments in joint ventures and associates |
169 |
164 |
Venture capital and other investments |
92 |
131 |
Total |
261 |
295 |
2024 |
2025 |
|
GBPm |
GBPm |
|
At start of year |
178 |
169 |
Share of results of joint ventures and associates |
43 |
44 |
Dividends received from joint ventures and associates |
(37) |
(40) |
Disposals and othe r |
- |
(7) |
Exchange translation differences |
(15) |
(2) |
At end of yea r |
169 |
164 |
RELX’s share |
||
2024 |
2025 |
|
GBPm |
GBPm |
|
Revenue |
121 |
116 |
Net profit for the year |
43 |
44 |
Total assets |
198 |
182 |
Total liabilities |
(97) |
(86) |
Net assets |
101 |
96 |
Goodwill |
68 |
68 |
Total |
169 |
164 |
| 2024 |
2025 |
|||||
Fixtures |
||||||
Land and |
Fixtures and |
Land and |
and |
|||
buildings |
equipment |
Total |
buildings |
equipment |
Total |
|
GBPm |
GBPm |
GBPm |
GBPm |
GBPm |
GBPm |
|
Cost |
||||||
At start of yea r |
134 |
373 |
507 |
110 |
288 |
398 |
Capital expenditure |
1 |
19 |
20 |
1 |
20 |
21 |
Disposals |
(25) |
(104) |
(129) |
(9) |
(50) |
(59) |
Exchange translation differences |
- |
- |
- |
(5) |
(13) |
(18) |
At end of yea r |
110 |
288 |
398 |
97 |
245 |
342 |
Accumulated depreciation |
||||||
At start of yea r |
92 |
316 |
408 |
74 |
242 |
316 |
Charge for the yea r |
5 |
29 |
34 |
4 |
22 |
26 |
Disposals |
(23) |
(103) |
(126) |
(10) |
(49) |
(59) |
Exchange translation differences |
- |
- |
- |
(4) |
(9) |
(13) |
At end of yea r |
74 |
242 |
316 |
64 |
206 |
270 |
Net book amount |
36 |
46 |
82 |
33 |
39 |
72 |
AT 31 DECEMBER 2024 |
Contractual cash flow (including interest) |
|||||||
Carrying |
Within |
More than |
||||||
amount |
1 year |
1-2 years |
2-3 years |
3-4 years |
4-5 years |
5 years |
Total |
|
GBPm |
GBPm |
GBPm |
GBPm |
GBPm |
GBPm |
GBPm |
GBPm |
|
Borrowings |
||||||||
Fixed rate borrowings |
(5,679) |
(763) |
(756) |
(541) |
(783) |
(862) |
(2,979) |
(6,684) |
Floating rate borrowings |
(762) |
(762) |
- |
- |
- |
- |
- |
(762) |
Lease liabilities |
(103) |
(43) |
(28) |
(19) |
(10) |
(4) |
(27) |
(131) |
(6,544) |
||||||||
Derivative financial liabilities |
||||||||
Cash inflows |
1,560 |
180 |
124 |
17 |
- |
- |
1,881 |
|
Cash outflows |
(1,575) |
(184) |
(126) |
(17) |
- |
- |
(1,902) |
|
Forward foreign exchange contracts |
(23) |
(15) |
(4) |
(2) |
- |
- |
- |
(21) |
Interest rate derivatives |
(119) |
(25) |
(22) |
(22) |
(22) |
(22) |
(22) |
(135) |
Cash inflows |
502 |
- |
- |
- |
- |
- |
502 |
|
Cash outflows |
(550) |
- |
- |
- |
- |
- |
(550) |
|
Cross-currency interest rate swaps |
(43) |
(48) |
– |
- |
- |
- |
- |
(48) |
(185) |
||||||||
Derivative financial assets |
||||||||
Cash inflows |
827 |
274 |
85 |
6 |
- |
- |
1,192 |
|
Cash outflows |
(788) |
(251) |
(77) |
(6) |
- |
- |
(1,122) |
|
Forward foreign exchange contracts |
53 |
39 |
23 |
8 |
- |
- |
- |
70 |
Interest rate derivatives |
21 |
3 |
5 |
5 |
4 |
3 |
16 |
36 |
74 |
||||||||
Total |
(6,655) |
(1,614) |
(782) |
(571) |
(811) |
(885) |
(3,012) |
(7,675) |
AT 31 DECEMBER 2025 |
Contractual cash flow (including interest) |
|||||||
Carrying |
Within |
More than |
||||||
amount |
1 year |
1-2 years |
2-3 years |
3-4 years |
4-5 years |
5 years |
Total |
|
GBPm |
GBPm |
GBPm |
GBPm |
GBPm |
GBPm |
GBPm |
GBPm |
|
Borrowings |
||||||||
Fixed rate borrowings |
(6,283) |
(846) |
(618) |
(874) |
(864) |
(1,237) |
(3,059) |
(7,498) |
Floating rate borrowings |
(887) |
(887) |
- |
- |
- |
- |
- |
(887) |
Lease liabilities |
(97) |
(35) |
(29) |
(18) |
(11) |
(6) |
(26) |
(125) |
(7,267) |
||||||||
Derivative financial liabilities |
||||||||
Cash inflows |
1,012 |
98 |
50 |
6 |
- |
- |
1,166 |
|
Cash outflows |
(1,017) |
(98) |
(50) |
(5) |
- |
- |
(1,170) |
|
Forward foreign exchange contracts |
(9) |
(5) |
- |
- |
1 |
- |
- |
(4) |
Interest rate derivatives |
(70) |
(16) |
(13) |
(15) |
(17) |
(11) |
(7) |
(79) |
Cash inflows |
19 |
19 |
19 |
19 |
200 |
228 |
504 |
|
Cash outflows |
(15) |
(15) |
(15) |
(15) |
(213) |
(236) |
(509) |
|
Cross-currency interest rate swaps |
(32) |
4 |
4 |
4 |
4 |
(13) |
(8) |
(5) |
(111) |
||||||||
Derivative financial assets |
||||||||
Cash inflows |
2,571 |
364 |
129 |
8 |
- |
- |
3,072 |
|
Cash outflows |
(2,519) |
(339) |
(119) |
(7) |
- |
- |
(2,984) |
|
Forward foreign exchange contracts |
75 |
52 |
25 |
10 |
1 |
- |
- |
88 |
Interest rate derivatives |
10 |
5 |
4 |
2 |
1 |
- |
12 |
24 |
Cash inflows |
19 |
19 |
19 |
19 |
19 |
462 |
557 |
|
Cash outflows |
(8) |
(8) |
(8) |
(8) |
(8) |
(398) |
(438) |
|
Cross-currency interest rate swaps |
27 |
11 |
11 |
11 |
11 |
11 |
64 |
119 |
112 |
||||||||
Total |
(7,266) |
(1,717) |
(616) |
(880) |
(874) |
(1,256) |
(3,024) |
(8,367) |
2023 |
2024 |
2025 |
|
GBPm |
GBPm |
GBPm |
|
Up to one month |
259 |
217 |
210 |
2 to 3 months |
130 |
130 |
132 |
4 to 6 months |
56 |
57 |
52 |
Greater than 6 months |
35 |
24 |
19 |
Total past due |
480 |
428 |
413 |
FAIR VALUE HEDGE RELATIONSHIPS |
31 December |
31 December |
||
2024 |
2025 |
|||
Principal |
Principal |
|||
amount |
amount |
|||
GBPm |
GBPm |
Fixed rate |
Floating rate |
|
€600m bond and €600m/$669.3m cross-currency interest rate |
||||
| swaps maturing 2025 |
(535) |
- |
1.3% |
USD SOFR+1.5% |
$750m bond and $750m interest rate swaps maturing 2030 |
(599) |
(558) |
3.0% |
USD SOFR+1.8% |
€750m bond and €750m interest rate swaps maturing 2031 |
(620) |
(654) |
3.8% |
Euribor+0.9% |
$500m bond and $500m interest rate swaps maturing 2032 |
(399) |
(372) |
4.8% |
USD SOFR+2.0% |
(2,153) |
(1,584) |
GAINS/(LOSSES) ON BORROWINGS AND RELATED DERIVATIVES |
Fair value |
|||||
AND CARRYING VALUES |
1 January |
movement |
Redemption/ |
Exchange |
31 December |
Carrying |
2023 |
gain/(loss) |
close-out |
gain/(loss) |
2023 |
values |
|
GBPm |
GBPm |
GBPm |
GBPm |
GBPm |
GBPm |
|
USD debt |
141 |
(22) |
(16) |
(6) |
97 |
(871) |
Related interest rate swaps |
(143) |
21 |
16 |
6 |
(100) |
(100) |
(2) |
(1) |
- |
- |
(3) |
(971) |
|
EUR debt |
70 |
(61) |
- |
(2) |
7 |
(1,600) |
Related interest rate swaps |
(70) |
60 |
- |
2 |
(8) |
(8) |
- |
(1) |
- |
- |
(1) |
(1,608) |
|
Total relating to USD and EUR debt |
211 |
(83) |
(16) |
(8) |
104 |
(2,471) |
Total related interest rate swaps |
(213) |
81 |
16 |
8 |
(108) |
(108) |
Net loss on borrowings and related |
||||||
derivatives/total carrying value |
(2) |
(2) |
- |
- |
(4) |
(2,579) |
GAINS/(LOSSES) ON BORROWINGS AND RELATED DERIVATIVES | Fair value | |||||
AND CARRYING VALUES | 1 January | movement | Redemption/ | Exchange | 31 December | Carrying |
2024 | gain/(loss) | close-out | gain/(loss) | 2024 | values | |
GBPm | GBPm | GBPm | GBPm | GBPm | GBPm | |
USD debt | 97 | 14 | - | 3 | 114 | (875) |
Related interest rate swaps | (100) | (16) | - | (3) | (119) | (119) |
(3) | (2) | - | - | (5) | (994) | |
EUR debt | 7 | 12 | - | 1 | 20 | (1,133) |
Related interest rate swaps | (8) | (12) | - | (1) | (21) | (21) |
(1) | - | - | - | (1) | (1,154) | |
Total relating to USD and EUR debt | 104 | 26 | - | 4 | 134 | (2,008) |
Total related interest rate swaps | (108) | (28) | - | (4) | (140) | (140) |
Net loss on borrowings and related | ||||||
derivatives/total carrying value | (4) | (2) | - | - | (6) | (2,148) |
GAINS/(LOSSES) ON BORROWINGS AND RELATED DERIVATIVES | Fair value | 31 | ||||
AND CARRYING VALUES | 1 January | movement | Redemption/ | Exchange | December | Carrying |
2025 | gain/(loss) | close-out | gain/(loss) | 2025 | values | |
GBPm | GBPm | GBPm | GBPm | GBPm | GBPm | |
USD debt | 114 | (39) | - | (8) | 67 | (855) |
Related interest rate swaps | (119) | 41 | - | 8 | (70) | (70) |
(5) | 2 | - | - | (3) | (925) | |
EUR debt | 20 | (29) | - | (2) | (11) | (664) |
Related interest rate swaps | (21) | 29 | - | 2 | 10 | 10 |
(1) | - | - | - | (1) | (654) | |
Total relating to USD and EUR debt | 134 | (68) | - | (10) | 56 | (1,519) |
Total related interest rate swaps | (140) | 70 | - | 10 | (60) | (60) |
Net (loss)/gain on borrowings and related | ||||||
derivatives/total carrying value | (6) | 2 | - | - | (4) | (1,579) |
Cost of |
Foreign |
|||
Interest rate |
hedging |
currency |
||
hedge reserve |
reserve |
hedge reserve |
Total |
|
GBPm |
GBPm |
GBPm |
GBPm |
|
Hedge reserve at 31 December 2023: (losses)/gains deferred |
- |
(4) |
40 |
36 |
(Losses)/gains arising in 2024 |
(5) |
6 |
10 |
11 |
Amounts recognised in income statement |
2 |
- |
(22) |
(20) |
Hedge reserve at 31 December 2024: (losses)/gains deferred |
(3) |
2 |
28 |
27 |
Gains/(losses) arising in 2025 |
2 |
(2) |
55 |
55 |
Amounts recognised in income statement |
1 |
- |
(37) |
(36) |
Hedge reserve at 31 December 2025: gains deferred |
- |
- |
46 |
46 |
Foreign |
Principal |
|
currency |
amount of |
|
hedge reserve |
hedges |
|
GBPm |
GBPm |
|
2026 |
20 |
563 |
2027 |
20 |
495 |
2028 |
6 |
234 |
2029 |
- |
14 |
Total |
46 |
1,306 |
2024 |
2025 |
|
GBPm |
GBPm |
|
Pre-publication costs |
302 |
291 |
Finished goods |
29 |
20 |
Total |
331 |
311 |
2024 |
2025 |
|
GBPm |
GBPm |
|
Trade receivables |
2,306 |
2,258 |
Loss allowance |
(122) |
(96) |
2,184 |
2,162 |
|
Prepayments and accrued income |
283 |
293 |
Current tax receivable |
42 |
13 |
Net finance lease receivable |
2 |
- |
Total |
2,511 |
2,468 |
2024 |
2025 |
|
GBPm |
GBPm |
|
At start of yea r |
119 |
122 |
Charge for the year |
17 |
15 |
Trade receivables written off |
(13) |
(40) |
Exchange translation differences |
(1) |
(1) |
At end of yea r |
122 |
96 |
2024 |
2025 |
|
GBPm |
GBPm |
|
Trade payables |
223 |
89 |
Accruals |
851 |
978 |
Social security and other taxes |
181 |
195 |
Other payables |
539 |
616 |
Deferred income |
2,328 |
2,390 |
Total |
4,122 |
4,268 |
| 2024 |
2025 |
|||||
Falling due |
Falling due |
Falling due |
Falling due |
|||
within |
in more than |
within |
in more than |
|||
1 year |
1 year |
Total |
1 year |
1 year |
Total |
|
GBPm |
GBPm |
GBPm |
GBPm |
GBPm |
GBPm |
|
Financial liabilities measured at amortised cost: |
||||||
Short-term bank loans, overdrafts and commercial paper |
762 |
- |
762 |
887 |
- |
887 |
Term debt |
- |
3,551 |
3,551 |
654 |
4,110 |
4,764 |
Lease liabilities |
38 |
65 |
103 |
30 |
67 |
97 |
Term debt in fair value hedging relationships |
492 |
1,516 |
2,008 |
- |
1,519 |
1,519 |
Term debt previously in fair value hedging relationships |
120 |
- |
120 |
- |
- |
- |
Total |
1,412 |
5,132 |
6,544 |
1,571 |
5,696 |
7,267 |
| 2024 |
2025 |
|||||||
Short-term |
Short-term |
|||||||
bank loans, |
bank loans, |
|||||||
overdrafts |
overdrafts |
|||||||
and |
and |
|||||||
commercial |
Lease |
commercial |
Lease |
|||||
paper |
Term debt |
liabilities |
Total |
paper |
Term debt |
liabilities |
Total |
|
GBPm |
GBPm |
GBPm |
GBPm |
GBPm |
GBPm |
GBPm |
GBPm |
|
Within 1 yea r |
762 |
612 |
38 |
1,412 |
887 |
654 |
30 |
1,571 |
Within 1 to 2 years |
- |
619 |
13 |
632 |
- |
436 |
13 |
449 |
Within 2 to 3 years |
- |
412 |
12 |
424 |
- |
696 |
13 |
709 |
Within 3 to 4 years |
- |
658 |
12 |
670 |
- |
702 |
12 |
714 |
Within 4 to 5 years |
- |
753 |
9 |
762 |
- |
1,056 |
9 |
1,065 |
After 5 years |
- |
2,625 |
19 |
2,644 |
- |
2,739 |
20 |
2,759 |
After 1 year |
- |
5,067 |
65 |
5,132 |
- |
5,629 |
67 |
5,696 |
Total |
762 |
5,679 |
103 |
6,544 |
887 |
6,283 |
97 |
7,267 |
| 2024 |
2025 |
|||||||
Short-term |
Short-term |
|||||||
bank loans, |
bank loans, |
|||||||
overdrafts |
overdrafts |
|||||||
and |
and |
|||||||
commercial |
Lease |
commercial |
Lease |
|||||
paper |
Term debt |
liabilities |
Total |
paper |
Term debt |
liabilities |
Total |
|
GBPm |
GBPm |
GBPm |
GBPm |
GBPm |
GBPm |
GBPm |
GBPm |
|
US dolla r |
446 |
2,246 |
21 |
2,713 |
828 |
2,667 |
12 |
3,507 |
Pound sterling |
8 |
- |
30 |
38 |
12 |
- |
38 |
50 |
Euro |
295 |
3,433 |
29 |
3,757 |
42 |
3,616 |
22 |
3,680 |
Other currencies |
13 |
- |
23 |
36 |
5 |
- |
25 |
30 |
Total |
762 |
5,679 |
103 |
6,544 |
887 |
6,283 |
97 |
7,267 |
2024 |
2025 |
|
GBPm |
GBPm |
|
At start of yea r |
113 |
89 |
Additions |
32 |
35 |
Remeasurement |
5 |
1 |
Disposals |
(9) |
- |
Depreciation |
(50) |
(37) |
Exchange translation differences |
(2) |
(1) |
At end of yea r |
89 |
87 |
2024 |
2025 |
|
GBPm |
GBPm |
|
Current |
||
Property |
(37) |
(29) |
Non-property |
(1) |
(1) |
Non-current |
||
Property |
(63) |
(65) |
Non-property |
(2) |
(2) |
Total |
(103) |
(97) |
CALLED UP SHARE CAPITAL – ORDINARY SHARES OF UK 14 ⁵¹/₁₁₆ PENCE EACH |
2024 |
2025 |
||
ALLOTTED, ISSUED AND FULLY PAID |
No. of shares |
GBPm |
No. of shares |
GBPm |
At start of year |
1,906,907,605 |
275 |
1,880,844,719 |
272 |
Issue of ordinary shares |
2,937,114 |
- |
2,215,646 |
- |
Cancellation of ordinary shares |
(29,000,000) |
(3) |
(55,000,000) |
(8) |
At end of yea r |
1,880,844,719 |
272 |
1,828,060,365 |
264 |
| Year ended 31 December |
||||
2024 |
2025 |
|||
Shares in |
Shares in |
|||
issue net of |
issue net of |
|||
treasury |
Shares in |
Treasury |
treasury |
|
shares* |
issue |
shares |
shares* |
|
(millions) |
(millions) |
(millions) |
(millions) |
|
At start of yea r |
1,881.5 |
1,880.8 |
(24.9) |
1,855.9 |
Issue of ordinary shares |
2.9 |
2.2 |
- |
2.2 |
Repurchase of ordinary shares |
(28.9) |
- |
(39.5) |
(39.5) |
Net release of shares by the employee benefit trust |
0.4 |
- |
0.4 |
0.4 |
Cancellation of ordinary shares |
- |
(55.0) |
55.0 |
- |
At end of year |
1,855.9 |
1,828.1 |
(9.0) |
1,819.1 |
Translation |
Hedge |
Other |
|||
Total |
reserve |
reserve |
reserves |
Total |
|
2024 |
2025 |
2025 |
2025 |
2025 |
|
GBPm |
GBPm |
GBPm |
GBPm |
GBPm |
|
At start of yea r |
2,180 |
567 |
21 |
1,738 |
2,326 |
Profit attributable to shareholders |
1,934 |
- |
- |
2,065 |
2,065 |
Dividends paid |
(1,121) |
- |
- |
(1,181) |
(1,181) |
Actuarial gains on defined benefit pension schemes |
43 |
- |
- |
5 |
5 |
Fair value movements on cash flow hedges |
11 |
- |
55 |
- |
55 |
Transfer to profit from cash flow hedge reserve |
(20) |
- |
(36) |
- |
(36) |
Tax recognised in other comprehensive income |
(8) |
- |
(5) |
(3) |
(8) |
Exchange differences on translation of foreign operations |
175 |
(438) |
- |
- |
(438) |
Cancellation of shares |
(850) |
- |
- |
(1,922) |
(1,922) |
Increase in share based remuneration reserve (including tax) |
79 |
- |
- |
79 |
79 |
Settlement of share awards |
(53) |
- |
- |
(62) |
(62) |
Acquisition of non ‐ controlling interests |
(44) |
- |
- |
(22) |
(22) |
At end of yea r |
2,326 |
129 |
35 |
697 |
861 |
KEY MANAGEMENT PERSONNEL REMUNERATION |
2023 |
2024 |
2025 |
GBPm |
GBPm |
GBPm |
|
Salaries, other short-term employee benefits and non-executive fees |
8 |
8 |
8 |
Share based remuneration* |
14 |
14 |
11 |
Total |
22 |
22 |
19 |
EXECUTIVE DIRECTORS |
Annual |
Share based |
|||||
Salary |
Benefits |
incentive |
remuneration* |
Pension* |
Total |
||
GBP’000 |
GBP’000 |
GBP’000 |
GBP’000 |
GBP’000 |
GBP’000 |
||
Total Executive Directors |
2023 |
2,190 |
97 |
3,808 |
14,354 |
241 |
20,690 |
2024 |
2,245 |
109 |
3,576 |
14,322 |
247 |
20,499 |
|
2025 |
2,360 |
116 |
3,810 |
11,016 |
260 |
17,562 |
2023 |
2024 |
2025 |
|
NON-EXECUTIVE DIRECTORS |
GBP’000 |
GBP’000 |
GBP’000 |
Fees and benefits |
1,566 |
1,781 |
1,812 |
Statement of |
|||||
| Income statement |
financial position |
||||
2023 |
2024 |
2025 |
2024 |
2025 |
|
Euro to sterling |
1.15 |
1.18 |
1.17 |
1.21 |
1.15 |
US dollar to sterling |
1.24 |
1.28 |
1.32 |
1.25 |
1.35 |
Share |
Reg |
|
Company name |
class |
office |
Australia |
||
Express VOI Pty Ltd |
Ordinary |
AUS2 |
Halkin Capital SPV 19 Pty Ltd |
Ordinary |
AUS2 |
IDVerse Pty Ltd |
Ordinary |
AUS2 |
LNRS Data Services (Australia) Pty Ltd |
Ordinary |
AUS1 |
OCR LABS APAC Holdings Pty Ltd |
Ordinary |
AUS2 |
OCR Labs ANZ Pty Ltd |
Ordinary |
AUS2 |
OCR Labs Global (Aus) Pty Ltd |
Ordinary |
AUS2 |
OCR Labs IDKit Pty Ltd |
Ordinary |
AUS2 |
OCR Labs IDVaaS Pty Ltd |
Ordinary |
AUS2 |
OCR Labs Pty Ltd |
Ordinary |
AUS2 |
RX Australia Pty Ltd |
Ordinary |
AUS1 |
RELX Holdings Australia Pty Ltd |
Ordinary |
AUS1 |
RELX Trading Australia Pty Limited |
Ordinary |
AUS1 |
Austria |
||
RELX Austria GmbH |
Ordinary |
AUT1 |
LexisNexis Verlag ARD ORAC GmbH |
Ordinary |
AUT1 |
Belgium |
||
LexisNexis B.V. |
Ordinary |
BEL1 |
Henchman B.V. |
Ordinary |
BEL2 |
Brazil |
||
Elsevier Editora Limitada |
Quotas |
BRA1 |
Gestora de Inteligencia de Credito S.A. (20%) 5 |
Preferred, Ordinary |
BRA6 |
LexisNexis Informações e Sistemas Empresariais Limitada |
Quotas |
BRA4 |
LexisNexis Serviços de Análise de Risco Limitada |
Quotas |
BRA5 |
MLex Brasil Mídia Mercadológica Limitada |
Quotas |
BRA3 |
Reed Exhibitions Alcântara Machado Limitada |
Quotas |
BRA2 |
Canada |
||
Corps Events IntCan. |
Class A Voting |
CAN3 |
Elsevier Canada Inc. |
Class A Common |
CAN2 |
LexisNexis Canada Inc. |
Class B Voting |
CAN1 |
PCLaw Time Matters Canada Inc. (51%) 5 |
Common |
CAN4 |
China |
||
Bakery China Exhibitions Co., Limited (25%) 6 |
Ordinary |
CHN1 |
Beijing Medtime Elsevier Education Technology Co., Limited |
Common |
CHN2 |
(49%) 5 |
||
Beijing Reed Elsevier Science and Technology Co Ltd 1 |
Common |
CHN19 |
C-One Energy (Guangzhou) Co., Limited |
Ordinary |
CHN5 |
Jingxunlingsi (Beijing) Information Technology Co Ltd 1 |
Ordinary |
CHN4 |
KeAi Communications Co., Limited (49%) 5 |
Ordinary |
CHN15 |
LexisNexis Information Technology Co. Limited |
Ordinary |
CHN4 |
LNRS Data Services (Greater China) Co. Ltd |
Ordinary |
CHN10 |
LexisNexis Risk Solutions (Shanghai) Information |
Registered Capital |
CHN7 |
Technologies Co Limited |
||
LNRS Data Services (Shanghai) Co Limited |
Ordinary |
CHN13 |
Reed Elsevier Information Technology (Beijing) Co Limited |
Common |
CHN3 |
Reed Exhibitions (China) Co., Limited |
Ordinary |
CHN4 |
Reed Exhibitions Hengjin Co., Limited (51%) 5 |
Ordinary |
CHN12 |
Reed Exhibitions Kuozhan (Shanghai) Co., Limited (60%) |
Ordinary |
CHN8 |
Reed Huabai Exhibitions (Beijing) Co., Limited (51%) 5 |
Ordinary |
CHN4 |
Reed Huaqun Exhibitions Co., Limited (52%) |
Ordinary |
CHN4 |
Reed Sinopharm Exhibitions Co., Limited (50%) 6 |
Ordinary |
CHN4 |
RX (China) Investment Co., Limited |
Ordinary |
CHN9 |
RX Huabo Exhibitions (Shenzhen) Co., Limited (65%) |
Ordinary |
CHN16 |
RX Huabo (Shenzhen) Technology Co. Limited 1 |
Ordinary |
CHN16 |
RX (Shenzhen) Co., Limited |
Ordinary |
CHN6 |
RX Technology (Shanghai) Co. Limited 1 |
Ordinary |
CHN18 |
Shanghai Datong Medical Information Technology Co., |
Ordinary |
CHN17 |
Limited |
||
Shanghai SinoReal Exhibitions Co., Limited (27.5%) 6 |
Ordinary |
CHN11 |
Z&R Exhibitions Co., Limited (27.5%) 6 |
Ordinary |
CHN14 |
Colombia |
||
LexisNexis Risk Solutions SAS |
Ordinary |
COL1 |
Denmark |
||
Elsevier A/S |
Ordinary |
DNK1 |
Share |
Reg |
|
Company name |
class |
office |
Egypt |
||
Elsevier Egypt LLC |
Ordinary |
EGY1 |
France |
||
Elsevier Holding France SAS |
Ordinary |
FRA1 |
Elsevier Masson SAS |
Ordinary |
FRA1 |
Fircosoft SAS |
Ordinary |
FRA6 |
GIE EDI Data (83%) (in liquidation) |
Ordinary |
FRA2 |
LexisNexis Business Information Solutions SA |
Ordinary |
FRA2 |
LexisNexis Business Information Solutions Holding SA |
Ordinary |
FRA4 |
LexisNexis SA |
Ordinary |
FRA2 |
RELX France SAS |
Ordinary |
FRA3 |
RELX France Services SAS |
Ordinary |
FRA6 |
RX France SAS |
Ordinary |
FRA3 |
SAFI Salon Français et Internationaux SA (50%) 6 |
Ordinary |
FRA5 |
Germany |
||
Elsevier GmbH |
Ordinary |
DEU2 |
LexisNexis GmbH |
Ordinary |
DEU3 |
LexisNexis Intellectual Property Solutions GmbH |
Ordinary |
DEU5 |
RELX Deutschland GmbH |
Ordinary |
DEU1 |
RX Deutschland GmbH |
Ordinary |
DEU6 |
Tschach Solutions GmbH |
Ordinary |
DEU4 |
Hong Kong |
||
JC Exhibition and Promotion Limited (65%) |
Ordinary |
HNK4 |
JYLN Sager Limited |
Ordinary |
HNK2 |
LNRS Data Services (China) Limited |
Ordinary |
HNK1 |
Reed Exhibitions Limited |
Ordinary |
HNK4 |
RELX (Greater China) Limited |
Ordinary |
HNK3 |
India |
||
Reed Elsevier Publishing (India) Private Limited |
Ordinary |
IND1 |
Reed Manch Exhibitions Private Limited |
Ordinary |
IND1 |
Reed Triune Exhibitions Private Limited |
Ordinary |
IND1 |
RELX India Private Limited |
Ordinary |
IND1 |
Indonesia |
||
PT Reed Exhibitions Indonesia (70%) 4 |
Series A, Series B |
IDN1 |
PT RELX Information Analytics Indonesia |
Common |
IDN2 |
Irish Republic |
||
Elsevier (Ireland) Limited |
Ordinary |
IRL2 |
LexisNexis Risk Solutions (Europe) Limited |
Ordinary |
IRL1 |
RELX International Finance Designated Activity Company |
Ordinary |
IRL1 |
Israel |
||
LexisNexis Israel Ltd. |
Ordinary |
ISR1 |
Italy |
||
Elsevier S.R.L |
Registered Capital |
ITA1 |
ICIS Italia S.R.L |
Quotas |
ITA2 |
RX Italy S.R.L |
Ordinary |
ITA1 |
Japan |
||
Elsevier Japan KK |
Ordinary |
JPN1 |
LexisNexis Japan KK |
Ordinary |
JPN2 |
RX Japan Ltd |
Ordinary |
JPN2 |
Kingdom of Saudi Arabia |
||
RX Arabia LLC |
Ordinary |
KSA1 |
Korea (Republic of) |
||
Elsevier Korea LLC |
Ordinary |
KOR1 |
LexisNexis Legal and Professional Service Korea Limited |
Ordinary |
KOR1 |
Reed Exhibitions Korea Limited |
Ordinary |
KOR2 |
Reed Exporum Limited (60%) |
Ordinary |
KOR3 |
Reed K. Fairs Limited (70%) |
Ordinary |
KOR4 |
Macau |
||
Reed Exhibitions Macau Limited |
Ordinary |
MAC1 |
Share | Reg | |
Company name | class | office |
Malaysia | ||
LexisNexis Malaysia Sdn Bhd | Ordinary | MYS1 |
Mexico | ||
Human API Technologies, S. de R.L. de C.V. | Fixed | MEX2 |
Masson-Doyma Mexico, S.A. | Ordinary | MEX1 |
Reed Exhibitions Mexico S.A. de C.V. | Fixed | MEX1 |
Netherlands | ||
AGRM Solutions C.V. | Partnership Interest | NLD1 |
Caselex B.V. | Ordinary | NLD1 |
Elsevier B.V. | Ordinary | NLD1 |
ICIS Benchmarking Europe B.V. | Ordinary | NLD1 |
LexisNexis Business Information Solutions B.V. | Ordinary | NLD1 |
LNRS Data Services B.V. | Ordinary | NLD1 |
RELX Employment Company B.V. | Ordinary | NLD1 |
RELX Finance B.V. | Ordinary | NLD1 |
RELX Holdings B.V. 3 | Ordinary | NLD1 |
RELX Nederland B.V. | Ordinary | NLD1 |
RELX Overseas B.V. | Ordinary RE | NLD1 |
New Zealand | ||
LexisNexis NZ Limited | Ordinary | NZL1 |
Philippines | ||
Reed Elsevier Shared Services (Philippines) Inc. | Common | PHL1 |
Poland | ||
AI Digital Contracts Sp. z.o.o. | Ordinary | POL1 |
Elsevier Sp. z.o.o. | Ordinary | POL2 |
Singapore | ||
Elsevier (Singapore) Pte Limited | Ordinary | SGP1 |
OCR Labs Pte Limited | Ordinary | SGP3 |
LNRS Data Services Pte Limited | Ordinary | SGP1 |
RE (HAPL) Pte Limited (in strike off) | Ordinary | SGP1 |
RELX (Singapore) Pte Limited | Ordinary | SGP2 |
South Africa | ||
LexisNexis (Pty) Limited (78%) | Ordinary | ZAF1 |
LexisNexis Risk Management (Pty) Limited (78%) | Ordinary | ZAF1 |
LexisNexis South Africa Shared Services (Pty) Limited | Ordinary | ZAF1 |
Reed Events Management (Pty) Limited (90%) | Ordinary | ZAF1 |
Reed Exhibitions (Pty) Limited (90%) | Ordinary | ZAF1 |
Reed Exhibitions Group (Pty) Limited (90%) | Ordinary | ZAF1 |
Reed Venue Management (Pty) Limited (90%) | Ordinary | ZAF1 |
RELX (Pty) Limited | Ordinary | ZAF1 |
Spain | ||
Elsevier Espana S.L.U | Participations | ESP1 |
Sweden | ||
Behaviometrics AB | A, B, and C shares | SWE1 |
Taiwan | ||
Elsevier Taiwan LLC | Ordinary | TWN1 |
Thailand | ||
RX BITEC (Thailand) Co., Ltd (64%) | Ordinary | THA1 |
RELX Holding (Thailand) Co., Limited | Ordinary | THA2 |
RELX Information Analytics (Thailand) Co., Limited | Ordinary | THA3 |
RX Holding (Thailand) Co., Limited (40%) 5 | A Ordinary, | B Preference THA4 |
Turkey | ||
Elsevier STM Bilgi Hizmetleri Limited Sirketi | Ordinary | TUR1 |
OCR Labs Turkey Teknoloji Çözümleri Ticaret Limited | Ordinary | TUR3 |
Ş irketi (in liquidation) | ||
Reed Tuyap Fuarcilik A.S. (50%) 4 6 | A Ordinary, B Ordinary | TUR2 |
United Arab Emirates | ||
Reed Exhibitions FZ-LLC | Ordinary | UAE1 |
RELX Middle East FZ-LLC | Ordinary | UAE2 |
United Kingdom | ||
Aistemos Limited | Ordinary | GBR3 |
Butterworths Limited | Ordinary | GBR3 |
Cordery Compliance Limited (71%) | Ordinary | GBR3 |
Share | Reg | |
Company name | class | office |
Crediva Limited | Ordinary | GBR4 |
Elsevier Limited | Ordinary | GBR5 |
LexisNexis Risk Solutions UK Limited | Ordinary | GBR4 |
LNRS Data Services Limited | Ordinary | GBR1 |
Mack-Brooks Exhibitions Limited | Ordinary | GBR2 |
MLex Limited | Ordinary | GBR3 |
OCR Labs Global Limited | Ordinary | GBR1 |
Offshore Europe (Management) Limited | Ordinary | GBR2 |
Offshore Europe Partnership (50%) | Partnership Interest | GBR2 |
RE (RCB) Limited | Ordinary | GBR1 |
RE Secretaries Limited | Ordinary | GBR1 |
RE (SOE) Limited | Ordinary | GBR2 |
Reed Events Limited | Ordinary | GBR2 |
Reed Exhibitions Limited | Ordinary | GBR2 |
RELX Finance Limited | Ordinary | GBR1 |
RELX Group plc 2 | Ordinary | GBR1 |
RELX (Holdings) Limited | Ordinary | GBR1 |
RELX (Investments) plc | Ordinary | GBR1 |
RELX Overseas Holdings Limited | Ordinary | GBR1 |
RELX (UK) Limited | Ordinary | GBR1 |
REV GP (UK) LLP (50%) | Membership Interest | GBR1 |
REV Venture Partners Limited | Ordinary | GBR1 |
REV V LP | Partnership Interest | GBR1 |
REV VI LP | Partnership Interest | GBR1 |
Tracesmart Limited | Ordinary | GBR4 |
United States | ||
Accuity Asset Verification Services Inc. | Common Stock | USA1 |
American Textile Machinery Exhibition-International, | Common Stock | USA2 |
Inc. (40%) 5 | ||
Aries Systems Corporation | Common Stock | USA2 |
Blue Sky Regulatory Solutions LLC | Common Stock | USA9 |
Dunlap-Hanna Publishers (50%) 6 | Partnership Interest | USA8 |
Elsevier Holdings Inc. | Common Stock | USA3 |
Elsevier Inc. | Common Stock | USA2 |
Elsevier STM Inc. | Common Stock | USA3 |
Enclarity, Inc. | Common Stock | USA1 |
Gaming Business Asia, LLC (50%) 6 | Membership Interest | USA2 |
Health Market Science, Inc. | Common Stock | USA1 |
HumanAPI Inc. | Common Stock | USA1 |
ID Analytics, LLC | Common Stock | USA1 |
Knovel Corporation | Common Stock | USA2 |
Knowable Inc | Common Stock | USA4 |
Legal InQuery Solutions Inc. | Common Stock | USA4 |
LexisNexis Claims Solutions Inc. | Common Stock | USA1 |
LexisNexis Coplogic Solutions Inc. | Common Stock | USA1 |
LexisNexis of Puerto Rico, Inc. | Common Stock | USA6 |
LexisNexis Risk Data Management, LLC | Membership Interest | USA1 |
LexisNexis Risk Holdings Inc. | Common Stock | USA1 |
LexisNexis Risk Solutions Inc. | Common Stock | USA1 |
LexisNexis Risk Solutions FL Inc. | Common Stock | USA1 |
LexisNexis Special Services Inc. | Common Stock | USA10 |
LexisNexis VitalChek Network Inc. | Common Stock | USA1 |
LNRS Data Services Inc. | Common Stock | USA1 |
Matthew Bender & Company, Inc. | Common Stock | USA2 |
MLex US, Inc. | Common Stock | USA2 |
OCR Labs Global (USA) Inc | Common Stock | USA1 |
PCLaw Time Matters LLC (51%) 6 | Membership Interest | USA7 |
Portfolio Media, Inc. | Common Stock | USA2 |
Reed Technology and Information Services LLC | Membership Interest | USA2 |
RELX Capital Inc. | Common Stock | USA3 |
RELX Inc. | Common Stock | USA2 |
RELX Risks Inc. | Common Stock | USA5 |
REV IV Partnership LP | Partnership Interest | USA3 |
SAFI Americas LLC (50%) 6 | Membership Interest | USA2 |
SageStream, LLC | Membership Interest | USA1 |
The Reed Elsevier Ventures 2011 Partnership LP | Partnership Interest | USA3 |
The Reed Elsevier Ventures 2013 Partnership LP | Partnership Interest | USA3 |
The Remick Publishers (50%) 6 | Partnership Interest | USA2 |
ThreatMetrix, Inc. | Common Stock | USA8 |
World Compliance, Inc. | Common Stock | USA1 |
Vietnam | ||
Reed Exhibitions Vietnam Limited Liability Company (64%) | Ordinary | VIE1 |
Registered offices | |
Australia | |
AUS1: | Tower 2, 475 Victoria Avenue, Chatswood NSW 2067 |
AUS2: | LexisNexis Risk Solutions, 201 Pacific Highway, Suite 4.03, Level 4, St |
Leonards | |
Austria | |
AUT1: | Trabrennstrasse 2A, 1020 Wien |
Belgium | |
BEL1: | Oudenaardseheerweg 129, 9810 Nazareth |
BEL2: | Moutstraat 64, bus 502, 9000 Ghent, Belgium |
Brazil | |
BRA1: | Av. Almirante Barroso 81, Sala 33A114, Rio de Janeiro, 20031-004 |
BRA2: | Rua Bela Cintra no. 1200, 10th floor, Sao Paulo, 01415-002 |
BRA3: | Avenida Paulista 2300, Andar Pilotis, Sao Paulo, SP 01 310-300 |
BRA4: | Rua Funchal, 538, 4º Andar, Conj. 42, Salas 4, 5 e 6, Vila Olímpia, Sao Paulo, |
04551-060 | |
BRA5: | Alameda Rio Negro, 161, conjunto 704, Alphaville Industrial, Barueri, São |
Paulo, 06464-000 | |
BRA6: | Alameda Araguaia, 2104, conjuntos 81A a 84A, Alphaville Industrial, Barueri, |
São Paulo, 06455-000 | |
Canada | |
CAN1: | 111 Gordon Baker Road, Suite 900, Toronto, Ontario, M2H 3R1 |
CAN2: | 500-4428 boul. Saint-Laurent Montréal (Québec) H2W 1Z5 |
CAN3: | 555 Richmond Street West, Suite 405, Toronto ON M5V 3B1 |
CAN4: | 199 Bay Street, 4000, Toronto, Ontario, M5L 1A9 |
China | |
CHN1: | Zhongkun Building, Room 612, Gaoliangqiaoxie Street, No. 59, Haidan |
District, Beijing, 100044 | |
CHN2: | Room 516, 5th Floor, Building 22, Area 11, No. 38, Xueyuan Road, Haidian |
District, Beijing, 100191 | |
CHN3: | Oriental Plaza, No. 1 East Chang An Ave, Tower W1, 7th Floor, Unit 1-7, |
Dong Cheng District, Beijing, 100738 | |
CHN4: | Ping An International Finance Centre, Room 1504-1505, 15th Floor, |
Tower A-101, 3-24 Floor, Xinyuan South Road, Chaoyang District, Beijing, | |
100027 | |
CHN5: | Unit B1303-1 & 1305, 13F Center Plaza, 161 Linhe Road West, Tianhe |
District Guangzhou | |
CHN6: | Unit 303, 3F, Tower 3 Kerry Plaza ,No.1 Zhong Xin Si Road, Fu Tian District, |
Shenzhen | |
CHN7: | Unit A-1, 5th Floor, No. 567, Tianshan West Road, Changning District, |
Shanghai | |
CHN8: | Intercontinental Center, 42F, 100 Yutong Road, Zhabei District, Shanghai, |
200070 | |
CHN9: | Room 319, 238 Jiangchangsan Road, Jing’an District, Shanghai |
CHN10: | Unit D-4, 8th Floor, No. 567 Tianshan West Road, Changning District |
CHN11: | Building 2, Room No. 3895, Changjiang Avenue, No. 161, Changliang Farm, |
Chongming County, Shanghai | |
CHN12: | Floor 2, No.979, Yunhan Road, Nicheng Town, Pudong New District, |
Shanghai, 200000 | |
CHN13: | Unit D-2, 8th Floor, No 567 Tianshan West Road, Changning District, |
Shanghai | |
CHN14: | A0208, 1st Floor, Building 2, Yard 66, Yanfu Road, Yancun Tow, Fangshan |
District, Beijing | |
CHN15: | 16 Donghuangchenggen North Street, Beijing, 100717 |
CHN16: | Shenzhen International Chamber of Commerce Tower, Room 1801-1802, |
1805, Fuhua 3rd Road, Futian District, Shenzhen, 518048 | |
CHN17: | 5/F Unit A, Digital China Centre No. 567 Tianshan West Road, ChangNing |
District, Shanghai, 200335 | |
CHN18: | Room 726, 1256-1258 Wan Rong Road, Jing An District, Shanghai |
CHN19: | Oriental Plaza, No. 1 East Chang An Ave, Tower W1, 7th Floor, Unit |
12C, Dong Cheng District, Beijing, 100738 | |
Colombia | |
COL1: | Philippe Prietocarrizosa & Uria Abogados, Carrera 9 No. 74-08 Oficina 105, |
Bogota, d.c., 76600 | |
Denmark | |
DNK1: | Niels Jernes Vej 10, 9220, Aalborg East |
Egypt | |
EGY1: | Land Mark Office Building, 2nd Floor, 90th Street, City Center, 5th |
Settlement, New Cairo, Cairo |
Registered offices | |
France | |
FRA1: | 65 Rue Camille Desmoulins, 92130, Issy les Moulineaux |
FRA2: | 141 rue de Javel, 75015, Paris |
FRA3: | 52 Quai de Dion Bouton, 92800, Puteaux |
FRA4: | Immeuble Technopolis, 350 rue Georges Besse, 30000, Nimes |
FRA5: | 6-8 rue Chaptal, 75009, Paris |
FRA6: | Immeuble Vivacity, 151-155 rue de Bercy, 75012, Paris |
Germany | |
DEU1: | Volklinger Strasse 4, 40219, Dusseldorf |
DEU2: | Bernhard-Wicki-Strasse 3/5 80636 München |
DEU3: | Heerdter Sandberg 30, 40549, Dusseldorf |
DEU4: | Stephanienstrasse 86, 76133 Karlsruhe |
DEU5: | Joseph-Schumpeter-Allee 33, 53227, Bonn |
DEU6: | Johannstrasse 1, 40476 Düsseldorf |
Hong Kong | |
HNK1: | Room 1917, 19/F, Lee Garden One, 33 Hysan Avenue, Causeway Bay |
HNK2: | Flat 1019B, 10/F, Liven House, No. 61-63 King Yip Street, Kwun Tong, |
Kowloon | |
HNK3: | 11/F Oxford House, Taikoo Place, 979 King’s Road, Quarry Bay |
HNK4: | 17th Floor, One Island East, Taikoo Place, 18 Westlands Road, Quarry Bay |
India | |
IND1: | 818, 8th Floor, Indraprakash Building, 21 Barakhamba Road, New Delhi, |
Delhi, 110001 | |
Indonesia | |
IDN1: | APL Tower Central Park 26th Floor Unit T3 Jl. S. Parman Kav., 28, Grogol, |
Pertamburan Jakarta Barat 11470 | |
IDN2: | Gedung World Trade Center, 3 Lt. 20 Spaces JL Jend Sudirman Kav 29-31, |
Karet Kuningan, Setiabudi,Kota Adm. Jakarta Selatan, DKI Jakarta 12940 | |
Irish Republic | |
IRL1: | Riverside One, Sir John Rogerson’s Quay, Dublin 2, DO2 X576 |
IRL2: | 4th Floor, South Block, Rockfield Central, Dundrum, Dublin, D16 R6VO |
Israel | |
ISR1: | Meitar, Attorneys at Law, 16 Abba Hillel Road, Ramat Gan 5250608 |
Italy | |
ITA1: | Via Marostica 1, 20146, Milan |
ITA2: | Studio Colombo e Associati, Via San Damiano 9, 20122, Milan |
Japan | |
JPN1: | 1-9-15 Higashi-Azabu, Minato-Ku Tokyo 106-0044 |
JPN2: | 11F, Yaesu Central Tower, Tokyo Midtown Yaesu, 2-2-1 Yaesu Chuo-ku, |
Tokyo 104-0028 | |
Kingdom of Saudi Arabia | |
KSA1: | Riyadh, Financial Boulevard 13519, Al Aqeeq District |
Korea (Republic of) | |
KOR1: | 206 Noksapyeong-daero, Yongsan-gu, 140-861, Seoul |
KOR2: | 1622-24 Block A, Tera Tower II, 201 Songpa-daero, Songpa-gu, Seoul |
KOR3: | Story 2003 Bldg, 5, Baekjegobun-ro 9-gil, Songpa-gu, Seoul, 05561, Republic |
of Korea | |
KOR4: | 1602-03 Block A, Tera Tower II, 201 Songpa-daero, Songpa-gu, Seoul, Korea |
Macau | |
MAC1: | Rua De Xangai, No. 175 Edif. Associacao Comercial de Macau, 11 Andar, |
Bloco K | |
Malaysia | |
MYS1: | Suite 29-1, Level 29, Vertical Corporate, Tower B, Avenue 10, The Vertical, |
59200 Bangsar South City, Kuala Lumpur | |
Mexico | |
MEX1: | Avenida Paseo de la Reforma 243, Piso 15, Col. Cuauhtemoc, Mexico City, |
06500 | |
MEX2: | Av. Real de Acueducto #240 Nùmero Interior 181, interior D, piso 18 , Col. |
Puerta de Hierro, Zapopan, Jalisco | |
Netherlands | |
NLD1: | Radarweg 29, 1043 NX Amsterdam |
Registered offices |
|
New Zealand |
|
NZL1: |
Level 1, 138 The Terrace, P.O. Box 472, Wellington 6011 |
Philippines |
|
PHL1: |
Building H, 2nd Floor, U.P. Ayalaland TechnoHub, Commonwealth Avenue, |
Quezon City, Metro Manila, 1101 |
|
Poland |
|
POL1: |
Plac Grunwaldzki 23-27, 50-365 Wroclaw |
POL2: |
Al. JJana Pawla II, 22, 00-133, Warszawa |
Singapore |
|
SGP1: |
3 Killiney Road, #08-01, Winsland House 1, 239519 |
SGP2: |
9 Raffles Place, #26-01, Republic Plaza, 048619 |
SGP3: |
21 Tan Quee Lan Street, #02-04, Heritage Place, 188108 |
South Africa |
|
ZAF1: |
Building 8, Country Club Estate Office Park, 21 Woodlands Drive, Woodmead, |
Gauteng, 2191 |
|
Spain |
|
ESP1: |
C/ Josep Tarradellas 20-30, 1º / 20029, Barcelona |
Sweden |
|
SWE1: |
Aurorum 8, 977 75 Lulea |
Taiwan |
|
TWN1: |
RM. N905, 9/F, No.96, Zhong Shan N. Road SEC.2, Taipei,10449 |
Thailand |
|
THA1: |
Sathorn Nakorn Building, Floor 32, No. 100/68-69 North Sathon Road, Silom, |
Bangrak, Bangkok, 10500 |
|
THA2: |
14th Floor, CTI Tower, 191/70-73 Ratchadapisek Road, Khwaeng Klongtoey, |
Klongtoey, Bangkok, 10110 |
|
THA3: |
The Offices at Central World, Office R06, 999/9 Rama I Road, Pathumwan, |
Bangkok 10330 |
|
THA4: |
No. 99, OSC Building, 4th Floor, Room No. S-01, Moo 5, KingKaeo Road, |
Racha Thewa Sub-district |
|
Bang Phli District, Samut Prakan Province |
|
Turkey |
|
TUR1: |
Maslak Mah. Bilim Sokak Sun Plaza Kat:13 Sisli-Maslak, Istanbul |
TUR2: |
Tuyap Fuar ve Kongre Merkezi, Cumhuriyet Mah. Hadimkoy Yolu Cad. No:9/4 |
, 34500 Buyukcekmece, Istanbul |
|
TUR3: |
Maslak Mah. Sumer Sok. Ayazaga Is Merkezi Sitesi B. Blok No:1B, Ic Kapi |
No:3, Sariyer, Istanbul |
|
United Arab Emirates |
|
UAE1: |
Office 303, 3rd Floor Arjaan Office Tower Al Sufouh Complex, PO Box 502425, |
Dubai Media City, Dubai |
|
UAE2: |
Al Sufouh Complex, Office nos. 404, 405, 406 & 407, Dubai Media City, Dubai |
United Kingdom |
|
GBR1: |
1-3 Strand, London, WC2N 5JR |
GBR2: |
Gateway House, 28 The Quadrant, Richmond, Surrey, TW9 1DN |
GBR3: |
Lexis House, 30 Farringdon Street, London, EC4A 4HH |
GBR4: |
Global Reach, Dunleavy Drive, Cardiff, CF11 0SN |
GBR5: |
125 London Wall, London, EC2Y 5AS |
United States |
|
USA1: |
1000 Alderman Dr., Alpharetta, GA 30005 |
USA2: |
230 Park Ave, New York, NY 10169 |
USA3: |
Suite 501, 1105 North Market St, Wilmington, DE 19801 |
USA4: |
9443 Springboro Pike, Miamisburg, OH 45342 |
USA5: |
c/o Aon Insurance Managers (USA) Inc, 100 Bank Street, Suite 630 |
Burlington, Vermont 05401 |
|
USA6: |
#1095 Wilson, Ste 3, San Juan, PR 00907 |
USA7: |
2235 Gateway Access Point, Suite 300, Raleigh, NC, 27607 |
USA8: |
101 Park Avenue, 24th Floor, New York, NY 10178 |
USA9: |
50 Hampshire Street, Cambridge MA 02139 |
USA10: |
1775 Greensboro Station Drive , Suite 425E, McLean VA 22102 |
Vietnam |
|
VIE1: |
2nd Floor, Kova Center, 92G-92H Nguyen Huu Canh Street, Ward no. 22, |
District. Binh Thanh, Ho Chi Minh City |
Company name |
Registration number |
Aistemos Limited |
08644182 |
Butterworths Limited |
02826955 |
Cordery Compliance Limited |
07931532 |
Crediva Limited |
06567484 |
Mack-Brooks Exhibitions Limited |
00967560 |
MLex Limited |
05488651 |
Offshore Europe (Management) Limited |
02318214 |
RE (RCB) Limited |
03396524 |
RE (SOE) Limited |
02330299 |
Reed Events Limited |
05893942 |
RELX (Holdings) Limited |
05807690 |
RELX (Investments) plc |
05810043 |
RELX Overseas Holdings Limited |
09489059 |
REV Venture Partners Limited |
04226986 |
Tracesmart Limited |
03827062 |